The total return over the past 12 months is -22.74% vs. +16.94% for the S&P 500. So far it's up +14.81% this year. Includes price appreciation + reinvested dividends.
| Category | 1Y (TTM) | 3Y | 5Y | 10Y | 15Y | 20Y |
|---|---|---|---|---|---|---|
| Price CAGR | (22.74%) | +8.40% | (6.59%) | (5.39%) | N/A | N/A |
| Total Return CAGR | (22.74%) | +8.40% | (6.59%) | (5.39%) | N/A | N/A |
| Revenue CAGR | +140.58% | +69.61% | +4.54% | +7.01% | N/A | N/A |
| Net Income CAGR | (163.27%) | N/A | N/A | N/A | N/A | N/A |
| EPS CAGR | (161.06%) | N/A | N/A | N/A | N/A | N/A |
| Free Cash Flow CAGR | N/A | N/A | N/A | N/A | N/A | N/A |
| Operating Cash Flow CAGR | N/A | N/A | N/A | N/A | N/A | N/A |
| Dividends CAGR | N/A | N/A | N/A | N/A | N/A | N/A |
Visualize historical growth rates over rolling horizons. Use the dropdown to select different metric vectors.
Agios Pharmaceuticals, Inc. (AGIO)
| Year | Start price | End price | AGIO Return | SPY Return | Outperformance |
|---|---|---|---|---|---|
| 2026(YTD) | $27.22 | $31.25 | +14.81% | +14.51% | +0.30% |
| 2025 | $32.86 | $27.22 | (17.16%) | +17.72% | (34.88%) |
| 2024 | $22.27 | $32.86 | +47.55% | +24.89% | +22.66% |
| 2023 | $28.08 | $22.27 | (20.69%) | +26.19% | (46.88%) |
| 2022 | $32.87 | $28.08 | (14.57%) | (18.17%) | +3.60% |
| 2021 | $43.33 | $32.87 | (24.14%) | +28.74% | (52.88%) |
| 2020 | $47.75 | $43.33 | (9.26%) | +18.37% | (27.63%) |
| 2019 | $46.11 | $47.75 | +3.56% | +31.22% | (27.66%) |
| 2018 | $57.17 | $46.11 | (19.35%) | (4.56%) | (14.79%) |
| 2017 | $41.73 | $57.17 | +37.00% | +21.70% | +15.30% |
Start and end prices are split-adjusted closing prices. Total return includes reinvested dividends, so it can differ from the price change.
